Less toxic fluorophores and advanced platforms expand scope.
Proteins for identifying myeloid-derived suppressor cells.
Getting it right is key as results are only as good as the samples.
Trials with CRISPR could be routine, once some issues are resolved
Tips on how to design and evaluate efficacy as well as troubleshooting...
Discover the trends playing out in drug discovery labs today.